{"id":"W1982733715","doi":"10.1016/j.ophtha.2012.02.003","title":"Verteporfin plus Ranibizumab for Choroidal Neovascularization in Age-Related Macular Degeneration","year":2012,"lang":"en","type":"article","venue":"Ophthalmology","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Verteporfin; Medicine; Ranibizumab; Macular degeneration; Choroidal neovascularization; Ophthalmology; Combination therapy; Regimen; Confidence interval; Visual acuity; Randomized controlled trial; Pro re nata; Surgery; Bevacizumab; Internal medicine; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004688764,0.0002885712,0.001140917,0.0003575684,0.0003117667,0.0003679563,0.0003594548,0.0005400862,0.001700083],"category_scores_gemma":[0.000579459,0.0001275935,0.0005550365,0.0002710794,0.0001691259,0.000493532,0.0001605853,0.0008267597,0.0002163067],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005950437,"about_ca_system_score_gemma":0.0005133345,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002169335,"about_ca_topic_score_gemma":0.004716652,"domain_scores_codex":[0.9997715,0.00006535036,0.00002919813,0.00002527656,0.00003434895,0.00007437538],"domain_scores_gemma":[0.9998837,0.00004193289,0.00001575335,0.000008499398,0.000006979103,0.00004311323],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2340239,0.007362811,0.01148824,0.000944136,0.001229661,0.006753152,0.0001757246,0.001928422,0.05281524,0.001242508,0.005901163,0.6761351],"study_design_scores_gemma":[0.2040611,0.2215253,0.3533565,0.0007572665,0.007324539,0.04006439,0.0007804885,0.02071784,0.07885312,0.003819396,0.06837635,0.0003636028],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9762772,0.0145203,0.0006182683,0.001116846,0.0003196108,0.0001738877,0.0001670472,0.0001422739,0.0066646],"genre_scores_gemma":[0.995419,0.002255875,0.0006936487,0.0001787745,0.0001436679,0.00004668358,0.0001175578,0.000009622931,0.001135124],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002169335,"threshold_uncertainty_score":0.005687296,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03061018583337337,"score_gpt":0.3212333938573483,"score_spread":0.2906232080239749,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}